Clinical Trial Update: Buspirone, Stress, and Attentional Bias to Marijuana Cues [Phase 2]

View source ↗

Summary

Phase 2 study evaluating buspirone for Cannabis Use Disorder, examining the impact of stress on attentional bias to marijuana cues; results posted (completed in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Use Disorder

Drugs mentioned

• Buspirone (buspirone)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Cannabis Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-04-07